Market-Moving News for October 3rd
Market-Moving News for October 3rd
LEVI: -12% | Levi Strauss & Co shares are trading lower after the company reported worse-than-expected Q3 sales results and issued its FY24 adjusted EPS guidance with its midpoint below estimates. The company began a strategic review for its Dockers brand and is exploring a potential sale or other strategic transactions.
LEVI：-12％ | Levi Strauss & Co的股價走低，此前該公司公佈的第三季度銷售業績低於預期，併發布了24財年調整後的每股收益指引，中點低於預期。該公司開始對其Dockers品牌進行戰略審查，並正在探索潛在的出售或其他戰略交易。
TOVX: 61% | Theriva Biologics Announces Outcome Of Data And Safety Monitoring Committee Review In Phase 1b/2a Clinical Trial Of SYN-004 In Allogeneic Hematopoietic Cell Transplant Recipients; The DSMC Has Recommended That The Study Proceed To Enroll Cohort 3
TOVX：61% | Theriva Biologics 公佈了針對異基因造血細胞移植受者的 SYN-004 1b/2a 期臨床試驗的數據和安全監督委員會審查結果；DSMC 已建議該研究繼續招收隊列 3
NVDA: 2% | Nvidia CEO Jensen Huang Says Demand For Next-Gen Blackwell GPU Platform Insane: 'Everyone Wants To Have The Most, And Everyone Wants To Be First'
NVDA：2% | 英偉達首席執行官黃延森表示，對下一代布萊克韋爾 GPU 平台的需求簡直太瘋狂了：「每個人都想擁有最多，每個人都想成爲第一個」
